AngioDynamics (ANGO)

12.20 -0.13  -1.05%  May 25, 11:00PM Go Pro
Watch this stock

AngioDynamics Performance

Historical performance is a good guide for the future, but it is imperfect. Pay attention to a company's history, but be realistic about what you can project into the future.

5 Year Total Returns Performance

Returns from price appreciation only give a partial view of the returns to an investor. This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested)

Returns -23.61%
Total Returns -23.61%

1 Year Total Returns Performance Comparison

Here are AngioDynamics's total returns compared to the market and some of its peers. High historical total returns are excellent - especially if you held the stock at the time - but returns can change direction quickly. To predict future performance, looking at the business is more important than looking at historic returns.

  • ANGO Total Returns
  • ^SPXTR Total Returns
  • AIS Total Returns
  • ICUI Total Returns
1 month total returns YTD total returns 1 year total returns* 3 year total returns
ANGO -2.32% -17.62% -20.62% -7.86%
^SPXTR -5.66% 5.70% 1.62% 54.07%
AIS -9.97% 31.36% 58.79% 489.8%
ICUI -1.46% 15.58% 22.58% 46.10%

* May differ from chart if one year ago today was not a trading day. Table uses the previous trading day as a base while chart uses the next trading day.

Fundamental Performance

Price vs Earnings

In the long run, the price and earnings of a company are correlated. If the two metrics are diverging, there should be a good reason why. Divergence without reason can signal danger or opportunity.

Price -34.62%
Earnings Per Share TTM -94.55%

Earnings Yield vs Dividend Yield

Yields show how much you are getting for the price you pay. For example, an earnings yield of 8% means that for every dollar you pay, you get 8 cents worth of current earnings. Take these numbers into account when buying to see if you are over-paying or getting a good deal.

Earnings Yield 0.25%
Dividend Yield 0.00%

Revenue and Earnings Growth

Revenues show how much the company is selling to customers, while net income is what remains for shareholders after the company pays its expenses. Revenue growth often persists over time, but net income is more fickle. Watch closely to see if revenue and income grow at similar rates.

Revenues TTM 220.32M
Net Income TTM 1.073M

Efficent Use of Assets

Profit margins show what percentage of every dollar of sales turns into earnings. Asset Uitlization shows how many dollars of sales a company gets for each dollar that the company invests in assets. Multiplying the two numbers together gives you Return on Assets which tells you approximately how efficiently the company invests money to earn more money.

Profit Margin -3.43%
Asset Utilization 0.4984

Reinvestment Strategy

Return on Invested Capital (ROIC) tells you how much income a company earned after investing $1 in its business. The Payout Ratio tells what percentage of the company's income it pays to shareholders instead of reinvesting in its own growth. Watch out for companies that pay out very little when their ROIC is low.

5 Year Average ROIC 0.0162
5 Year Average Payout Ratio 0.00
Get Performance for

ANGO News

AngioDynamics Completes Acquisition of Navilyst Medical http://stks.co/3vuI $ANGO
about 5 days ago by evcgroup
AngioDynamics Shareholders Approve Share Issuance for Navilyst Medical Acquisition http://stks.co/3qGr $ANGO
about 12 days ago by evcgroup
RT @MedDevice ABC on Dr. Cunningham of @VeinClinics on the VenaCure 1470 for varicose veins bit.ly/VeinClinicsofAmericaBrentwood $ANGO
about 20 days ago by evcgroup
$ANGO filed latest Quarterly Report http://stks.co/3GyA
about 48 days ago by MarketBrief
$ANGO New 52 Week Low - Crossed daily lows support.
about 48 days ago by TradeIdeasQuant
AngioDynamics Goes Red
Apr 09, 12:00PM Fool
Listen to $ANGO Q3 2012 earnings call - live at 04:30 PM, ondemand after - http://stks.co/3E55
about 53 days ago by earningscast
AngioDynamics Receives FDA Clearance for NeverTouch Direct Procedure Kit to be Used With VenaCure EVLT System http://stks.co/2OQd $ANGO
about 103 days ago by evcgroup
AngioDynamics Launches DuraFlow 2 Chronic Hemodialysis Catheter http://stks.co/2InF $ANGO
about 109 days ago by evcgroup
$ANGO 200 Day SMA Cross - Price crossed below 200 day SMA (14.4842). Confirmed by volume.
about 117 days ago by TradeIdeasQuant
$ANGO Q3 adj-EPS from 9-11c to 7-9c, Q4 from 11-13c to 10-12c, FY12 from 41-45c to 38-42c
about 124 days ago by Street_Insider
$ANGO shares sink: cuts Q3, Q4, FY12 guidance
about 124 days ago by Street_Insider
$ANGO filed latest Quarterly Report http://stks.co/1ocw
about 142 days ago by MarketBrief
$ANGO filed latest Quarterly Report http://stks.co/1nMi
about 143 days ago by MarketBrief
Listen to $ANGO Q2 2012 earnings call - live at 04:30 PM, ondemand after - http://stks.co/1nIm
about 143 days ago by earningscast
$ANGO Reports Q2 EPS $0.09 vs $0.12 Est; Revenues $58.10M vs $56.26M Est
about 143 days ago by Benzinga
AngioDynamics' new VenaCure 1470 in Houston http://stks.co/1PWW $ANGO
about 173 days ago by evcgroup
Listen to $ANGO at piper jaffray health care conference - live at 03:00 PM, ondemand after - http://stks.co/1KNG
about 179 days ago by earningscast
AngioDynamics Expands Senior Leadership Team $ANGO http://stks.co/11Gy
about 201 days ago by evcgroup
RT @EVCGroup RT @MedDevice Here's where varicose vein treatment is today, a solid summary in Vascular Disease Management goo.gl/j3Vk1 $ANGO
about 205 days ago by evcgroup
$ANGO filed latest Quarterly Report http://stks.co/ZxW
about 229 days ago by MarketBrief
$ANGO Reports Q1 EPS $0.08 vs $0.08 Est; Revenue $54.4M vs $53.86M Est; Announces Stock Repurchase Authorization of up to $20M
about 234 days ago by Benzinga
AngioDynamics $ANGO shares falling as FDA issues warning letter over NY plant inspection
about 271 days ago by Street_Insider
$NEOP Big Hedge funds need 2 buy & drive it up to $9,see how much Martin can lose! $CMN,$CALP,$ANGO,$OSUR,$DNDN,$PFE,$TEVA,$MRK,$JNJ,$NVS
about 355 days ago by funkybunch
After falling about 3% before the Nasdaq could halt, shares of $ANGO have bounced upon resumption, now down about 1.2% from today's close.
about 488 days ago by Street_Insider

Recent Quotes

Symbol Price Chg Chg % Market Cap
ANGO 12.20 -0.13 -1.05% 306.46M
ANGN 5.85 +0.20 +3.54% 22.93M
ANF 36.23 +0.94 +2.66% 3.069B
ANEN 19.05 +0.06 +0.32% 283.65M
ASPS 57.98 -1.04 -1.76% 1.352B
ASP 11.61 -0.05 -0.46%
ASNA 18.90 -0.02 -0.11% 2.896B
ASML 46.00 -0.22 -0.48% 19.03B
ASMI 35.28 -0.28 -0.79% 1.954B
ASM 1.24 -0.01 -0.72% 25.52M
You must be signed in to use watchlists.
Sign In or Register
Create Watchlist from Stock Quotes
Close